DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

1.40 0.03 (2.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LXRX $1.40 2.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.39
Previous Close $1.37
Daily Range $1.35 - $1.40
52-Week Range $1.04 - $2.57
Market Cap $720.7M
P/E Ratio -6.85
Dividend (Yield) $0.00 (0.0%)
Volume 642,950
Average Daily Volume 1,032,737
Current FY EPS -$0.20

Sector

Healthcare

Industry

Drugs

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexicon-genetics.com/

News & Commentary Rss Feed

7 States Where Diabetes Prevalence Is the Highest

More than 29 million people now have diabetes, but its occurrence is the highest within these seven U.S. states.

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Commercialization Agreement for Telotristat Etip

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Commercialization Agreement for Telotristat Etiprate with Ipsen for Ex-North America/Japan Licensing Conference (Transcript)

Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 15.7% - Tale of the Tape

Thursday’s Top 10 After-Hours Stocks on the Move

Lexicon Announces A Publication In The American Diabetes Association's Journal, Diabetes Care

Lexicon Pharmaceuticals' CEO Presents at Morgan Stanley Healthcare Conference (Transcript)

Benzinga's Top Downgrades

For Lexicon Pharmaceuticals, No News Remains Bad News

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q2 2014 Results - Earnings Call Transcript

Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape

See More LXRX News...

LXRX's Top Competitors

LXRX $1.40 (2.19%)
Current stock: LXRX
AMGN $147.26 (0.01%)
Current stock: AMGN
GILD $110.71 (3.29%)
Current stock: GILD
BIIB $321.67 (1.77%)
Current stock: BIIB